Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial
Resource Type
Article
Authors
Antoniotti, Carlotta ; Rossini, Daniele ; Pietrantonio, Filippo ; Catteau, Aurélie ; Salvatore, Lisa ; Lonardi, Sara ; Boquet, Isabelle ; Tamberi, Stefano ; Marmorino, Federica ; Moretto, Roberto ; Ambrosini, Margherita ; Tamburini, Emiliano ; Tortora, Giampaolo ; Passardi, Alessandro ; Bergamo, Francesca ; Kassambara, Alboukadel ; Sbarrato, Thomas ; Morano, Federica ; Ritorto, Giuliana ; Borelli, Beatrice ; Boccaccino, Alessandra ; Conca, Veronica ; Giordano, Mirella ; Ugolini, Clara ; Fieschi, Jacques ; Papadopulos, Alexia ; Massoué, Clémentine ; Aprile, Giuseppe ; Antonuzzo, Lorenzo ; Gelsomino, Fabio ; Martinelli, Erika ; Pella, Nicoletta ; Masi, Gianluca ; Fontanini, Gabriella ; Boni, Luca ; Galon, Jérôme ; Cremolini, Chiara
Source
In The Lancet Oncology July 2022 23(7):876-887
Subject
Primary Research Articles
Language
ISSN
1470-2045